Psychometric properties of the Perform Questionnaire: A brief scale for assessing patient perceptions of fatigue in cancer

Supportive Care in Cancer

Volumn 19, Issue 5, 2011, Pages 657-666

  Baró, Eva ^a   Carulla, Joan ^b   Cassinello, Javier ^c   Colomer, Ramón ^d,e   Mata, Jesús García ^f   Gascón, Pere ^g   Gasquet, Jose Antonio ^h   Rodríguez, Cesar A ⁱ   Valentín, Vicente ^j  

^a 3D Health Research   (Spain)

^b Hospital General Mateu Orfila   (Spain)

^c HOSPITAL UNIVERSITARIO DE GUADALAJARA   (Spain)

^d CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^e MD ANDERSON CANCER CENTER   (Spain)

^f Instituto de Investigación Biomédica Ourense Vigo Pontevedra   (Spain)

^g HOSPITAL CLÍNIC   (Spain)

^h Amgen SA   (Spain)

ⁱ HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^j HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

more..

Author keywords

Fatigue; Keywords cancer; Oncology; Questionnaire; Reliability; Validity

Indexed keywords

HEMOGLOBIN;

ADULT; ANEMIA; ARTICLE; ATTITUDE TO ILLNESS; BREAST CANCER; CANCER FATIGUE; CANCER PATIENT; DISEASE SEVERITY; FEASIBILITY STUDY; FEMALE; HEALTH BELIEF; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTERNAL CONSISTENCY; MAJOR CLINICAL STUDY; MALE; PERFORM QUESTIONNAIRE; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; RELIABILITY; SCORING SYSTEM; SELF CONCEPT; TEST RETEST RELIABILITY; VALIDATION STUDY;

AGED; ANEMIA; ATTITUDE TO HEALTH; FATIGUE; FEASIBILITY STUDIES; FEMALE; HEMOGLOBINS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEOPLASMS; PROSPECTIVE STUDIES; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SPAIN;

EID: 79958210839     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-010-0878-x     Document Type: Article

References (41)

1. Borneman T, Piper BF, Sun VC et al (2007) Implementing the Fatigue Guidelines at one NCCN member institution: process and outcomes. J Natl Compr Canc Netw 5:1092-1101 (Pubitemid 350247715)
2. Deimling GT, Bowman KF, Wagner LJ (2007) The effects of cancer-related pain and fatigue on functioning of older adult, longterm cancer survivors. Cancer Nurs 30:421-433 (Pubitemid 350145154)
3. Reyes-Gibby CC, Aday LA, Anderson KO et al (2006) Pain, depression, and fatigue in community-dwelling adults with and without a history of cancer. J Pain Symptom Manage 32:118-128 (Pubitemid 44108582)
4. National Comprehensive Cancer Network (2008) Clinical practice guideline in oncology. Cancer-related fatigue. Version 4. http://www.nccn.org/ professionals/physician-gls/PDF/fatigue.pdf. Accessed Dec 2, 2008
5. Vogelzang NJ, Breitbart W, Cella D et al (1997) Patient, caregiver and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. Semin Hematol 34:4-12 (Pubitemid 27319139)
6. Henry DH, Viswanathan HN, Wade SM et al (2007) The patient's experience of fatigue: cross-sectional study of cancer. J Support Oncol 5:18-19 (Pubitemid 46929442)
7. Hofman M, Ryan JL, Figueroa-Moseley CD et al (2007) Cancer-related fatigue: the scale of the problem. Oncologist 12:4-10
8. Strömgren AS, Goldschmidt D, Groenvold M et al (2007) Self-assessment in cancer patients referred to palliative care: a study of feasibility and symptom epidemiology. Cancer 94: 512-520
9. Curt GA, Breitbart W, Cella D et al (2000) Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition. Oncologist 5:353-360
10. Jacobsen PB, Donovan KA, Vadaparampil ST, Small BJ (2007) Systematic review and meta-analysis of psychological and activity-based interventions for cancer-related fatigue. Health Psychol 26:660-667 (Pubitemid 350161067)
11. Luctkar-Flude MF, Groll DL, Tranmer JE, Woodend K (2007) Fatigue and physical activity in older adults with cancer: a systematic review of the literature. Cancer Nurs 30:E35-E45 (Pubitemid 47417675)
12. Sood A, Barton DL, Bauer BA, Loprinzi CL (2007) A critical review of complementary therapies for cancer-related fatigue. Integr Cancer Ther 6:8-13
13. Ahlberg K, Ekman T, Gaston-Johansson F, Mock V (2003) Assessment and management of cancer-related fatigue in adults. Lancet 362:640-650 (Pubitemid 37013308)
14. Brown P, Clark MM, Atherton P et al (2006) Will improvement in quality of life (QOL) impact fatigue in patients receiving radiation therapy for advanced cancer? Am J Clin Oncol 29:52-58
15. Apolone G (2003) Clinical and outcome research in oncology. The need for integration. Health Qual Life Outcomes 1:3
16. Baró E, Carulla J, Cassinello J et al (2009) Development of a new questionnaire to assess patient perceptions of cancer-related fatigue: item generation and item reduction. Value Health 12:130-138
17. Wolfe F, Pincus T, Thompson AK, Doyle J (2003) The assessment of rheumatoid arthritis and the acceptability of self-report questionnaires in clinical practice. Arthritis Rheum 49:59-63 (Pubitemid 36286130)
18. Cella D (1998) Factors influencing quality of life in cancer patients: anemia and fatigue. Semin Oncol 25:S43-S46
19. Cella D, Tulsky DS, Gray G et al (1993) The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 11:570-579 (Pubitemid 23071057)
20. Prieto L, Alonso J, Lamarca R, Wright BD (1998) Rasch measurement for reducing the items of the Nottingham Health Profile. J Outcome Meas 2:285-301
21. Prieto L, Alonso J, Lamarca R (2003) Classical test theory versus Rasch analysis for quality of life questionnaire reduction. Health Qual Life Outcomes[serial online]; 1:27. http://www.hqlo.com/content/1/1/27. Accessed Dec 2, 2008
22. Cronbach LJ (1951) Coefficient alpha and the internal structure of tests. Psychometrika 16:297-334
23. Nunnally J, Bernstein IH (1994) Psychometric theory, 3rd edn. McGraw-Hill, New York
24. Streiner DL, Norman GR (1995) Health measurement scales: a practical guide to their development and use, 2nd edn. Oxford University Press, Oxford
25. Karnofsky DA, Burchenal JH (1949) The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod CM (ed) Evaluation of chemotherapeutic agents. Columbia University Press, New York, p 196
26. Cohen J (1988) Statistical power analysis for the behavioral sciences, 2nd edn. Lawrence Erlbaum, Hillsdale
27. Patrick DL, Gagnon DD, Zagari MJ, Epoetin Alfa Study Group et al (2003) Assessing the clinical significance of health-related quality of life (HrQOL) improvements in anaemic cancer patients receiving epoetin alfa. Eur J Cancer 39:335-345 (Pubitemid 36140051)
28. SAS Institute. October. http://www.sas.com/industry/pharma/
29. US Department of Health and Human Services FDA Center for Drug Evaluation and Research, US Department of Health and Human Services FDA Center for Biologics Evaluation and Research, US Department of Health and Human Services FDA Center for Devices and Radiological Health (2006) Guidance for industry: patient-reported outcome measure: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes [serial online]; 4:79. http://www.hqlo.com/content/4/1/79. Accessed Dec 2, 2008
30. Wild D, Grove A, Martin M et al (2005) ISPOR Task Force for Translation and Cultural Adaptation. Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR Task Force for Translation and Cultural Adaptation. Value Health 8:94-104
31. McHorney CA, Tarlov AR (1995) Individual-patient monitoring in clinical practice: are available health status surveys adequate? Qual Life Res 4:293-307
32. Meek PM, Nail LM, Barsevick A et al (2000) Psychometric testing of fatigue instruments for use with cancer patients. Nurs Res 49:181-190
33. Cella D (1997) The Functional Assessment of Cancer Therapy-Anemia (FACT-An) scale: a new tool for the assessment of outcomes in cancer anemia and fatigue. Semin Hematol 34:S13-S19
34. Yellen SB, Cella DF, Webster K et al (1997) Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage 13:63-74 (Pubitemid 27147321)
35. Cella D, Eton DT, Lai JS et al (2002) Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales. J Pain Symptom Manage 24:547-561 (Pubitemid 36120443)
36. Palumbo A, Petrucci MT, Lauta VM et al (2005) Italian Multiple Myeloma Study Group. Correlation between fatigue and hemoglobin level in multiple myeloma patients: results of a crosssectional study. Haematologica 90:858-860
37. Holzner B, Kemmler G, Greil R et al (2002) The impact of hemoglobin levels on fatigue and quality of life in cancer patients. Ann Oncol 13:965-973 (Pubitemid 34752693)
38. Okuyama T, Akechi T, Kugaya A et al (2000) Development and validation of the cancer fatigue scale: a brief three-dimensional self-rating scale for assessment of fatigue in cancer patients. J Pain Symptom Manage 19:5-14 (Pubitemid 30067618)
39. Okuyama T, Tanaka K, Akechi T et al (2001) Fatigue in ambulatory patients with advanced lung cancer prevalence, correlated factors, and screening. J Pain Symptom Manage 22:554-564 (Pubitemid 32547444)
40. Stein KD, Martin SC, Hann DM et al (1998) A multidimensional measure of fatigue for use with cancer patients. Cancer Pract 6:143-152 (Pubitemid 28225636)
41. Gentile S, Delarozière JC, Favre F et al (2003) Validation of the French 'multidimensional fatigue inventory' (MFI 20). Eur J Cancer Care (Engl) 12:58-64